期刊文献+

我国区域伦理委员会的前生、今世和来生 被引量:3

Discussion on the Past,Present and Future of Chinese Regional Ethics Committee
下载PDF
导出
摘要 目的概述我国区域伦理委员会的发展史,结合当前国家政策法规展望未来发展趋势。方法查阅国内有关区域伦理委员会的文献并结合国家政策法规阐述其发展脉络。结果我国区域伦理委员会是在国家创新药物发展需求下正式提出,各地区正不断成立,其功能可定位在审查、培训等方面。具有独立公正和高效审查的优点,需明确职责和审查范围、受主管部门监管、高标准选择委员、强化审查和事务性管理、接受认证评估、加强信息化建设以保证审查质量和效率。结论我国区域伦理委员会是应时之需,未来需不断探索其功能定位,针对性采取措施解决存在的问题,补充性提升我国伦理审查水平。 Objective: To summarize the development histoxT of regional ethics committee in China, and look forward to the future development trend in combination with current national policies and regulations. Methods: This paper looked up domestic literatures about regional ethics committee and expounded its development context combining with national policies and regulations. Results: Regional ethics committee of our counhT was formally put forward under the demand for the development of innovative drugs in the country, various regions were continu- ously established, and their functions could be located in aspects of review and training. It had the advantages of independence, fairness, and efficient review, and it needed to clarify responsibilities and the scope of review, be supervised by competent department, select members with high standard, strengthen review and transactional man- agement, accept certification assessment and strengthen information construction, so as to ensure the quality and efficiency of review. Conclusion : Regional ethics committee in China is the need of the times, and it needs to con- stantly explore its function and orientation, take targeted measures to solve existing problems and complementarily improve the level of Chinese ethical review in the future.
作者 周吉银 曾圣雅 刘丹 ZHOU Jiyin;ZENG Shengya;LIU Dan(National Drug Clinical Trial Institution,the Second Affiliated Hospital of Army Medical University,Chongqing 400037,Chin)
出处 《中国医学伦理学》 2018年第8期977-980,共4页 Chinese Medical Ethics
关键词 区域伦理委员会 伦理审查 审查质量 Regional Ethics Committee Ethical Review Quality of Review
  • 相关文献

参考文献6

二级参考文献21

  • 1黄洁夫.临床科研中的伦理学问题[J].中国医学伦理学,2006,19(1):1-3. 被引量:54
  • 2关健,罗林枝,徐苓.加强伦理委员会职能 促进医院临床研究健康发展[J].中华医学科研管理杂志,2006,19(2):105-107. 被引量:15
  • 3赵帼英,江滨,史录文.我国药物临床试验伦理委员会运作模式及监管机制探讨[J].中国药事,2007,21(1):25-28. 被引量:25
  • 4郑兴东,姜北,陆伟,孙亚林,贺佳.医学科研伦理审查监管问题的思考[J].第二军医大学学报,2007,28(6):667-669. 被引量:26
  • 5Anon. Multicenter Trial[EB/OL]. [2011-04-01]. http://en. wikipedia.org/wiki/M ulticenter_trial.
  • 6国际多中心临床试验研讨会将于12月9日至10日在上海召开[EB/OL].[2011-04-01].http://www.scrcnet.org/cnews.asp?id=87.
  • 7于晓蓉.美国辉瑞拿患儿做新药试验制药巨头终成被告[EB/OL].(20010915)[2011-04-11].http://finance.sina.com.cn/j/20010915/107638.html.
  • 8新文化报.美国辉瑞公司药物试验致11名儿童死亡[EB/OL].(2009-07-31)[2011-04-01].http://news.ifeng.com/society/2/200907/0731_344_1277892.shtml.
  • 9Anon. About the Bioethics Program [EB/OL].[2011-04-01]. http://www. unesco. org/new/en/social-- and -- human -- se ences/ themes/bioethics/about-bioethics/.
  • 10国际医学科学组织理事会,世界卫生组织.涉及人的生物医学研究国际伦理准则[R].陈元方,译,胡庆澧,校.日内瓦:世界卫生组织,2002:15.

共引文献83

同被引文献22

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部